Using urinary inflammatory biomarkers to develop novel phenotypes of prematurity-associated lung disease

Presented at the American Thoracic Society International Conference 2026

Previous
Previous

FunLBM to Cluster Trajectories of Air Quality Data from Low-Cost Monitors

Next
Next

Continuous Improvement of The Nova Scotia Lung Wellness Clinic